로딩 중…
StockDiggingStockDigging

진바이오텍

086060· KOSDAQ
₩4,450+3.61%
2026-06-19

Price Chart

진바이오텍+3.97%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap38.32B KRW
Revenue89.44B KRW
Net Income628.5M KRW
Total Assets79.46B KRW
Net Assets55.10B KRW
Employees43
Value
P/E60.96x
P/B0.70x
P/S0.43x
EV/EBITDA49.27x
FCF Yield10.06%
Profitability
ROE1.14%
ROA0.79%
Op. Margin1.04%
Revenue Growth-5.91%
Earnings Growth-26.15%
Financial Health
Debt Ratio144.22%
Total Debt16.28B KRW
FCF3.86B KRW
Cash8.74B KRW
Current Ratio3.01x
Net Debt/EBITDA8.11x
Dividend
Div. Yield1.16%
Div. Growth0.00%
Performance
1Y Return3.97%
1M Return14.10%
From 52W High-25.71%
1Y MDD-35.14%
Trading
Volume153,094 shares
Foreign Own.6.76%
Per Share
EPS417 KRW
BPS6,399 KRW

Company Info

CEO 이찬호
Employees 43
Founded 2000
HQ 충청남도 공주시, KR

Jin Biotek, established in 2000 and headquartered in Gongju-si, Chungcheongnam-do, was founded to manufacture and sell functional feed additives using beneficial microorganisms, listing on KOSDAQ in 2006. In 2011, it acquired Dawon Chemical Co., Ltd., an animal pharmaceutical company, and supplies natural, eco-friendly feed ingredients and additives based on solid-state fermentation technology. The company focuses on developing technologies and products for environmental improvement, greenhouse gas reduction, and pet food, snacks, and supplements, driven by future technology R&D and ESG management.